Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 5
1994 2
1995 4
1996 4
1997 1
1999 1
2009 1
2010 1
2012 2
2013 2
2014 2
2018 1
2019 1
2020 3
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; ML18147 Study Investigators. Bennouna J, et al. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16. Lancet Oncol. 2013. PMID: 23168366 Clinical Trial.
Hydroxyurea-induced dermatomyositis-like eruption.
Senet P, Aractingi S, Porneuf M, Perrin P, Duterque M. Senet P, et al. Among authors: porneuf m. Br J Dermatol. 1995 Sep;133(3):455-9. doi: 10.1111/j.1365-2133.1995.tb02677.x. Br J Dermatol. 1995. PMID: 8547004 Review.
Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G, Nguyen Y, Amarger S, Aubineau M, Bibes B, Blanchard-Delaunay C, Boccon-Gibod I, Bouillet L, Coppo P, Dalmas MC, Debord-Peguet S, Defendi F, Demoreuil C, Du-Thanh A, Gayet S, Hadjadj J, Jeandel PY, Launay D, Ly KH, Avoy CM, Niault M, Ollivier Y, Pelletier F, Porneuf M, Roos-Weil D, Fain O, Gobert D. Kalmi G, et al. Among authors: porneuf m. J Allergy Clin Immunol Pract. 2024 Jan;12(1):212-222. doi: 10.1016/j.jaip.2023.10.017. Epub 2023 Oct 14. J Allergy Clin Immunol Pract. 2024. PMID: 37844846
[Carcinoma cuniculatum arising in necrobiosis lipoidica].
Porneuf M, Monpoint S, Barnéon G, Alirezai M, Guillot B, Guilhou JJ. Porneuf M, et al. Ann Dermatol Venereol. 1991;118(6-7):461-4. Ann Dermatol Venereol. 1991. PMID: 1897832 Review. French. No abstract available.
[Segmental neurilemmomatosis].
Porneuf M, Ducret JP, Bonvalet D, Perrin P, Duterque M. Porneuf M, et al. Ann Dermatol Venereol. 1993;120(11):824-7. Ann Dermatol Venereol. 1993. PMID: 8210133 Review. French. No abstract available.
Pseudo-melanoma revealing Laugier-Hunziker syndrome.
Porneuf M, Dandurand M. Porneuf M, et al. Int J Dermatol. 1997 Feb;36(2):138-41. doi: 10.1111/j.1365-4362.1997.tb03076.x. Int J Dermatol. 1997. PMID: 9109016 No abstract available.
[Intermittent fever with cutaneous manifestations...].
Duhamel E, Le Moal S, Porneuf M, Dien G. Duhamel E, et al. Among authors: porneuf m. Rev Med Interne. 1999;20 Suppl 2:281s-282s. doi: 10.1016/s0248-8663(99)80465-2. Rev Med Interne. 1999. PMID: 10422170 French. No abstract available.
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.
Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators. Aparicio T, et al. Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26. Eur J Cancer. 2018. PMID: 29807237 Free article.
30 results